Day: November 21, 2022

All amounts expressed in US dollars TORONTO, Nov. 21, 2022 (GLOBE NEWSWIRE) — Barrick Gold Corporation (NYSE:GOLD)(TSX:ABX) (“Barrick,” the “Company” or the “Offeror”) today announced the expiration and final results of its previously announced tender offer (the “Offer”) to purchase for cash any and all of its 5.250% Notes due 2042 (the “Notes”). The Offer was made pursuant to the terms and subject to the conditions set forth in the Offer to Purchase dated November 14, 2022 relating to the Notes (the “Offer to Purchase”) and the accompanying notice of guaranteed delivery (the “Notice of Guaranteed Delivery” and, together with the Offer to Purchase, the “Tender Offer Documents”). Capitalized terms used but not defined in this announcement have the meanings given to them in the Offer to Purchase. Set forth in the table below is the...

Wi-Fi NOW Supports and Promotes All Things Wi-Fi to Make High-Quality, High-Performance W-Fi Available to Everyone, Everywhere Akoustis Adds to Wi-Fi NOW’s Growing, Global Thought LeadershipCharlotte, N.C., Nov. 21, 2022 (GLOBE NEWSWIRE) — Akoustis Technologies, Inc. (NASDAQ: AKTS) (“Akoustis” or the “Company”), an integrated device manufacturer (IDM) of patented bulk acoustic wave (BAW) high-band RF filters for mobile and other wireless applications, announced that it has joined the Wi-Fi NOW industry association as an Official RF Filter Partner, alongside major thought leaders including Cisco, Eero, Linksys, Intel, Netgear, and many more. Wi-Fi NOW was founded in 2015 as a media, event, training, and advisory organization dedicated to serving the global Wi-Fi industry. Since then, Wi-Fi NOW has quickly grown to support hundreds...

HOUSTON, Nov. 21, 2022 (GLOBE NEWSWIRE) — Aravive, Inc. (Nasdaq: ARAV), a late clinical-stage oncology company developing targeted therapeutics to treat metastatic disease, today announced that Gail McIntyre, Ph.D., DABT, Chief Executive Officer and Rudy Howard, Chief Financial Officer will be presenting a corporate overview and participating in 1×1 meetings at the Piper 34th Annual Healthcare Conference being held on November 29 – December 1, 2022 in New York, NY.Piper 34th Annual Healthcare Conference – November 29-December 1, 2022Title: Aravive (ARAV) Company PresentationDate: Wednesday, November 30, 2022Time: 3:30 – 3:50 PM ESTParticipant: Gail McIntyre, Ph.D., DABT, CEO, AraviveWebcast: Registration Link – Click HereA replay of the session will be available following the conference through the Aravive...

CINCINNATI, Nov. 21, 2022 (GLOBE NEWSWIRE) — Paycor HCM, Inc. (Nasdaq: PYCR) (“Paycor”), a leading provider of human capital management (HCM) software, today announced that the company will participate in the Credit Suisse 26th Annual Technology Conference in Scottsdale, Arizona. The presentation is scheduled for Tuesday, November 29, 2022 at 11:40 am Mountain Time (1:40 pm Eastern Time). The presentation will be webcast live and accessible for replay for a limited time under the “Events & Presentations” section of Paycor’s Investor Relations website at https://investors.paycor.com/. About Paycor Paycor’s human capital management (HCM) platform modernizes every aspect of people management, from recruiting, onboarding and payroll to career development and retention, but what really sets us apart is our focus...

TORONTO, Nov. 21, 2022 (GLOBE NEWSWIRE) — Discovery Silver Corp. (TSX-V: DSV, OTCQX: DSVSF) (“Discovery” or the “Company”) is pleased to announce results from the first 15 Feasibility Study drill holes on its flagship Cordero silver project (“Cordero” or “the Project”) located in Chihuahua State, Mexico. These holes consisted of upgrade and expansion drilling of the proposed open pit and were drilled subsequent to the data cut-off date for the Pre-Feasibility Study (“PFS”). The Pre-Feasibility Study is progressing well and remains on track to be delivered in early 2023. Highlight intercepts from this current set of drill holes include:77 m averaging 126 g/t AgEq1 (46 g/t Ag, 0.08 g/t Au, 0.7% Pb and 1.4% Zn) from 218 m and 22 m averaging 265 g/t AgEq1 (83 g/t Ag, 0.10 g/t Au, 1.8% Pb and 3.2% Zn) from 374 m in hole C22-656. 96...

CHATHAM, N.J., Nov. 21, 2022 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, today announced that Seth Lederman, M.D., Chief Executive Officer of Tonix Pharmaceuticals, will deliver an oral presentation at the World Antiviral Congress 2022, which will be held in San Diego, Calif., November 28 – December 1, 2022. A copy of the presentation will be available under the Scientific Presentations tab of the Tonix website at www.tonixpharma.com following the conference. Additional meeting information can be found on the World Antiviral Congress website here. Oral Presentation DetailsTitle: Development of fully human monoclonal antibodies against SARS-CoV2 using peripheral B-cells from COVID-19 survivors  Location: Loews Coronado Bay Resort, San Diego, Calif.Date: November...

Fosgonimeton demonstrates improvement on diverse biomarkers of neurodegeneration BOTHELL, Wash., Nov. 21, 2022 (GLOBE NEWSWIRE) — Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, today announced that additional biomarker data from the completed, exploratory ACT-AD Phase 2 study of fosgonimeton (ATH-1017) in patients with mild-to-moderate Alzheimer’s disease was selected as a late-breaking poster presentation at the 15th Clinical Trials on Alzheimer’s Disease (CTAD) conference, taking place November 29 – December 2, 2022, in San Francisco, California and virtually. Presentation Details: Title: Fosgonimeton provides congruent benefit on diverse biomarkers of neurodegeneration, significantly correlating...

TORONTO, Nov. 21, 2022 (GLOBE NEWSWIRE) — Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company focused on the research and development of light activated Photo Dynamic Compounds (“PDCs”) and their associated drug formulations, used to destroy various cancers, bacteria and viruses, safely and effectively, announces the grant of stock options. The Company has granted an aggregate of 7,860,000 stock options to directors, officers, employees & advisory board members pursuant to the Company’s stock option plan. The options granted, are exercisable at a price of CDN$0.25 per share and vest over a three-year period and expire five years from the date of the grant. The stock option plan was last approved by the shareholders of the Company at the Annual General...

MALVERN, Pa., Nov. 21, 2022 (GLOBE NEWSWIRE) — TELA Bio, Inc. (“TELA”), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy, today announced that the Company will participate in the Piper Sandler 34th Annual Healthcare Conference on November 30th, 2022. TELA’s management is scheduled to present at the Piper Sandler 34th Annual Healthcare Conference on Wednesday, November 30th, 2022, at 11:30 am ET. Interested parties can access the live and archived webcast at ir.telabio.com. About TELA Bio, Inc. TELA Bio, Inc. (NASDAQ: TELA) is a commercial-stage medical technology company focused on providing innovative technologies that optimize clinical outcomes...

VANCOUVER, British Columbia, Nov. 21, 2022 (GLOBE NEWSWIRE) — Anfield Energy Inc. (TSX.V: AEC; OTCQB: ANLDF; FRANKFURT: 0AD) (“Anfield” or “the Company”) is pleased to announce that it has expanded its claim holdings in the uranium-rich Artillery Peak project area, located in Mohave County, Arizona (the “Claims”). The additional 54 Claims are contiguous to to Anfield’s current project in the Date Creek Basin and increase Anfield’s claim holdings in the area to 119. In addition, the Company has commissioned BRS Inc., an engineering firm, to complete an NI 43-101 uranium resource report for its combined Date Creek Basin/Artillery Peak projects. As stated in Anfield’s November 15 news release, historical records indicate a potential uranium resource in the Artillery Peak/Date Creek Basin area of approximately 2.8 million pounds of...